Placement Announced
Quince Therapeutics placement
US$115m raised
Announced 18 May 2026 · NASDAQ: QNCX
Advisers
Quince Therapeutics
Issuer
Not disclosed
Lead managers
- Legal adviser
- Placement agent
Other advisers
- Financial adviser
- Issuer
- Quince Therapeutics
- Issuer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Pharma, Rare Disease
Similar deals
- Avalyn Pharma IPO Apr 2026 · US$300m · Biotech
- Research Alliance Corporation III placement Jul 2026 · US$100m · Biotech
- Werewolf Therapeutics placement Aug 2026 · US$150m · Biotech
- Agomab Therapeutics NV IPO Feb 2026 · US$200m · Biotech
- Seaport Therapeutics IPO Apr 2026 · US$255m · Biotech


